[Drug-induced impaired spermatogenesis].
Hayashi
Tetsuo
T
Department of Urology, Saitama Medical Center, Saitama Medical School.
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000009:adverse effects; D003937:Diagnosis, Differential; D012739:Gonadal Steroid Hormones / Q000009:adverse effects; D006633:Histamine Antagonists / Q000009:adverse effects; D006801:Humans; D008297:Male; D009845:Oligospermia / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D011379:Prognosis; D011619:Psychotropic Drugs / Q000009:adverse effects; D013091:Spermatogenesis
D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D002121:Calcium Channel Blockers; D012739:Gonadal Steroid Hormones; D006633:Histamine Antagonists; D011619:Psychotropic Drugs